Pressure BioSciences, Inc. develops and commercializes pressure-based technologies for the life sciences, food and beverage, nutraceutical, pharmaceutical, and other industries. The company’s platform is designed to use precisely controlled high-pressure processes to alter, preserve, extract, or formulate biological and chemical materials.
The company’s principal technologies include Pressure Cycling Technology, which applies alternating cycles of pressure for applications such as sample preparation and biomolecular research, and Ultra Shear Technology (UST). UST is intended to produce stable, high-quality nanoemulsions and other formulations for products including beverages, supplements, personal-care products, and certain pharmaceutical or wellness applications. Pressure BioSciences offers related equipment, processing systems, consumables, and contract services.
Pressure BioSciences has historically served customers through research, industrial, and commercial applications, with an emphasis on expanding the use of its high-pressure systems in areas such as food safety, ingredient delivery, and advanced product formulation. The company is based in the United States and has been led by founder and longtime chief executive Richard T. Schumacher.
AI Generated. May Contain Errors.
